US Patent Issued to SHENZHEN SALUBRIS PHARMACEUTICALS on Dec. 30 for "Uses of complex of angiotensin II receptor antagonist metabolite and NEP inhibitor in treating heart failure" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,246, issued on Dec. 30, was assigned to SHENZHEN SALUBRIS PHARMACEUTICALS Co. LTD. (Guangdong, China).

"Uses of complex of angiotensin II receptor antagonist metabolite and NEP inhibitor in treating heart failure" was invented by Jingchao Sun (Guangdong, China) and Xiaolong Jing (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Uses of a complex of an angiotensin II receptor antagonist metabolite and a NEP inhibitor in treating heart failure, specifically related are uses of complex in preparing a medicament for use in heart failure with reduced ejection fraction (HFrEF)."

The patent was filed on Sept. 18, 2020, under Application No....